Awards and Grants Opportunities

Through the lens of scientific innovation and pioneering new ideas, the American Lung Association Research Institute champions the next generation of lung health scientists to independence and beyond.

For 120 years the American Lung Association has focused on driving excellence and innovation through research. Today, through our Research Institute, we continue to support trailblazing research, novel ideas and innovative approaches with the goal of eliminating lung disease and improving life for those living with lung disease. Together, we are investing in brilliant scientific minds of the future and supporting science with the potential to improve prevention, detection and treatment options.

Get notified

Sign up to get email notifications about funding opportunities.
Sign up

2024-2025 Grant applications are currently closed; please revisit the website in August 2024 for the next grant cycle opportunities.

Current Funding Opportunities

  • Allergic Respiratory Diseases Award$75,000/year for up to two years
    Jointly funded with the American Academy of Allergy, Asthma & Immunology (AAAAI), this award supports allergic respiratory disease research by investigators with a primary faculty appointment in an allergy-immunology division.
  • Catalyst Award$50,000/year for up to two years
    For mentored early career scientists ascending toward independence, this award supports junior investigators conducting basic science, behavioral, clinical or translational research into lung health and disease.
  • Dalsemer Interstitial Lung Disease Award$50,000/year for up to two years 
    For mentored early career scientists ascending toward independence, this award provides seed monies to junior investigators for researching the mechanisms and biology of interstitial lung disease.
  • Emerging Respiratory Pathogen Award: $100,000/year for up to two years (Letter of Intent required)
    This award supports investigators to advance knowledge of COVID-19 and other novel respiratory viruses with pandemic potential. Successful applicants have evidence of ongoing excellence and productivity in a related field.
  • Hastings Innovation Award for Interstitial Lung Disease: $75,000/year for up to two years
    This award is geared toward independent investigators conducting basic, clinical or translational research in interstitial lung disease. Must have held an NIH K- or R-type award within three years prior to applying, but not more than one R01.
  • Innovation Award$75,000/year for up to two years
    This award is geared toward independent investigators who are conducting basic science, behavioral, clinical or translational research in lung health or disease. Must have held an NIH K- or R-type award within three years prior, but not more than one R01.
  • Lung Cancer Discovery Award: $100,000/year for up to two years (Letter of Intent required)
    This award will support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our understanding of lung cancer and improving diagnostic, clinical and treatment methods.
  • Public Policy & Public Health Award$50,000/year for up to two years
    This award is designed to stimulate and inform important public policy debates around healthy air and lung disease. The intent is to support research on and evaluation of existing public policy and public health programs, as well as pilot new ideas.

Application Information

Terms & Conditions

Learn more about the Terms and Conditions governing our Awards and Grants Program.

To Apply

It is strongly recommended that applicants thoroughly read the Program Descriptions and Terms and Conditions to determine eligibility and to ensure accurate preparation of an application.

Application materials are available through proposal CENTRAL.

Anticipated Timeline
  • July 1, 2023: New research term begins 
  • August 7, 2023: New award cycles announced; applications available through proposalCENTRAL 
  • Early Fall: September 22, 2023: Lung Cancer Discovery Award letters of intent  (LOI) due
  • Extended to October 9, 2023: Emerging Respiratory Pathogen Award letter of intent (LOI) due
  • Late Fall: November 1, 2023: All LOI outcome notifications emailed to all applicants 
  • December 15, 2023: All applications are due through proposalCENTRAL 
  • January-April 2024: Administrative review and scientific peer review
  • June 2024: Outcome notifications emailed to all applicants
  • June 30, 2024: Research term ends
Eligibility

While eligibility varies by award type, the following requirements apply to all awards: 

  • Candidates must be U.S. citizens or foreign nationals holding one of the following visa immigration statuses:
    • permanent resident (Green Card), 
    • exchange visitor (J-1), 
    • temporary worker in a specialty occupation (H-1B), 
    • Canadian or Mexican citizen engaging in professional activities (TN), 
    • Australians in Specialty Occupation (E-3 visa) 
    • temporary worker with extraordinary abilities in the sciences (O-1)
  • Candidates must be employed by a U.S. not-for-profit institution. 
  • Candidates are only allowed to submit 1 application per review cycle.

Applicants who apply for more than one grant or award will forfeit any chance of funding. Applicants deemed ineligible for a particular award, or who do not follow the instructions provided, may be disqualified.

Questions

Answers to frequently asked questions about our Awards & Grants.

Technical questions: contact proposal CENTRAL at [email protected] or 1-800-875-2562.

Questions on the Awards and Grants program: email [email protected].

Freedom From Smoking Clinic
, | May 29, 2024
Freedom From Smoking Clinic
Detroit, MI | May 29, 2024